{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:48:45Z","timestamp":1793836125210,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T00:00:00Z","timestamp":1558396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MSD Australia","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4065-5","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T11:07:50Z","timestamp":1558436870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-3488","authenticated-orcid":false,"given":"C.","family":"Keighley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C-A.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Darvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hajkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. C.","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Van Hal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,21]]},"reference":[{"issue":"4","key":"4065_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72(4):1103\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"7\u20138","key":"4065_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11046-017-0146-4","volume":"182","author":"DP Kofteridis","year":"2017","unstructured":"Kofteridis DP, Valachis A, Dimopoulou D, Andrianaki AM, Christidou A, Maraki S, et al. Factors influencing non-albicans Candidemia: a case-case-control study. Mycopathologia. 2017;182(7\u20138):665\u201372.","journal-title":"Mycopathologia."},{"issue":"13","key":"4065_CR3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198\u2013208.","journal-title":"N Engl J Med"},{"issue":"11","key":"4065_CR4","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1128\/JCM.01283-12","volume":"50","author":"SR Lockhart","year":"2012","unstructured":"Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol. 2012;50(11):3435\u201342.","journal-title":"J Clin Microbiol"},{"key":"4065_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2016.00915","volume":"7","author":"R Rajendran","year":"2016","unstructured":"Rajendran R, Sherry L, Deshpande A, Johnson EM, Hanson MF, Williams C, et al. A prospective surveillance study of Candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front Microbiol. 2016;7:915.","journal-title":"Front Microbiol"},{"issue":"10","key":"4065_CR6","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3201\/eid1210.060389","volume":"12","author":"S Chen","year":"2006","unstructured":"Chen S, Slavin M, Nguyen Q, Marriott D, Playford EG, Ellis D, et al. Active surveillance for candidemia, Australia. Emerg Infect Dis. 2006;12(10):1508\u201316.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"4065_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/tid.12613","volume":"18","author":"DR Andes","year":"2016","unstructured":"Andes DR, Safdar N, Baddley JW, Alexander B, Brumble L, Freifeld A, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the transplant-associated infection surveillance network (TRANSNET). Transpl Infect Dis. 2016;18(6):921\u201331.","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"4065_CR8","doi-asserted-by":"publisher","first-page":"e0176576","DOI":"10.1371\/journal.pone.0176576","volume":"12","author":"F Barchiesi","year":"2017","unstructured":"Barchiesi F, Orsetti E, Mazzanti S, Trave F, Salvi A, Nitti C, et al. Candidemia in the elderly: what does it change? PLoS One. 2017;12(5):e0176576.","journal-title":"PLoS One"},{"issue":"6","key":"4065_CR9","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1128\/AAC.00195-16","volume":"60","author":"M Puig-Asensio","year":"2016","unstructured":"Puig-Asensio M, Fernandez-Ruiz M, Aguado JM, Merino P, Lora-Pablos D, Guinea J, et al. Propensity score analysis of the role of initial antifungal therapy in the outcome of Candida glabrata bloodstream infections. Antimicrob Agents Chemother. 2016;60(6):3291\u2013300.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4065_CR10","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/cc7964","volume":"13","author":"DJ Marriott","year":"2009","unstructured":"Marriott DJ, Playford EG, Chen S, Slavin M, Nguyen Q, Ellis D, et al. Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care. 2009;13(4):R115.","journal-title":"Crit Care"},{"issue":"11","key":"4065_CR11","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/cid\/ciw610","volume":"63","author":"EG Playford","year":"2016","unstructured":"Playford EG, Lipman J, Jones M, Lau AF, Kabir M, Chen SC, et al. Problematic dichotomization of risk for intensive care unit (ICU)-acquired invasive candidiasis: results using a risk-predictive model to categorize 3 levels of risk from a multicenter prospective cohort of Australian ICU patients. Clin Infect Dis. 2016;63(11):1463\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"4065_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/cid\/cis305","volume":"54","author":"M Kollef","year":"2012","unstructured":"Kollef M, Micek S, Hampton N, Doherty JA, Kumar A. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54(12):1739\u201346.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4065_CR13","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","volume":"49","author":"M Morrell","year":"2005","unstructured":"Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4065_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","volume":"54","author":"L Ostrosky-Zeichner","year":"2011","unstructured":"Ostrosky-Zeichner L, Pappas PG, Shoham S, Reboli A, Barron MA, Sims C, et al. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses. 2011;54(1):46\u201351.","journal-title":"Mycoses."},{"issue":"12b","key":"4065_CR15","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/imj.12597","volume":"44","author":"SC Chen","year":"2014","unstructured":"Chen SC, Sorrell TC, Chang CC, Paige EK, Bryant PA, Slavin MA. Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J. 2014;44(12b):1315\u201332.","journal-title":"Intern Med J"},{"issue":"4","key":"4065_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1\u201350.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4065_CR17","doi-asserted-by":"publisher","first-page":"73 e1","DOI":"10.5694\/mja15.00657","volume":"204","author":"AR Burrell","year":"2016","unstructured":"Burrell AR, McLaws ML, Fullick M, Sullivan RB, Sindhusake D. SEPSIS KILLS: early intervention saves lives. Med J Aust. 2016;204(2):73 e1\u20137.","journal-title":"Med J Aust"},{"issue":"4","key":"4065_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633\u20138.","journal-title":"Clin Infect Dis"},{"key":"4065_CR19","first-page":"315","volume-title":"PCR protocols: a guide to methods and applications","author":"T White","year":"1990","unstructured":"White T, Bruns T, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis M, Gelfand D, Sninsky J, et al., editors. PCR protocols: a guide to methods and applications. New York: Academic Press; 1990. p. 315\u201322."},{"key":"4065_CR20","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement M27-S4","author":"Clinical Laboratory Stadards Institute (CLSI)","year":"2012","unstructured":"Clinical Laboratory Stadards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement M27-S4. Wayne, PA: CLSI; 2012."},{"key":"4065_CR21","unstructured":"Clinical Laboratory Stadards Institute (CLSI) Epidemiological Cutoff Values for Antifungal Susceptibility Testing \u2013 First edition; Approved standard M59. Wayne, PA, USA; 2016."},{"issue":"1","key":"4065_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12879-017-2636-x","volume":"17","author":"D Li","year":"2017","unstructured":"Li D, Xia R, Zhang Q, Bai C, Li Z, Zhang P. Evaluation of candidemia in epidemiology and risk factors among cancer patients in a cancer center of China: an 8-year case-control study. BMC Infect Dis. 2017;17(1):536.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"4065_CR23","doi-asserted-by":"publisher","first-page":"O245","DOI":"10.1111\/1469-0691.12380","volume":"20","author":"M Puig-Asensio","year":"2014","unstructured":"Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, et al. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect. 2014;20(4):O245\u201354.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"4065_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/clinids\/17.4.662","volume":"17","author":"BS Ang","year":"1993","unstructured":"Ang BS, Telenti A, King B, Steckelberg JM, Wilson WR. Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis. 1993;17(4):662\u20136.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 6","key":"4065_CR25","doi-asserted-by":"publisher","first-page":"S437","DOI":"10.1093\/cid\/cir110","volume":"52","author":"JF Fisher","year":"2011","unstructured":"Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis. 2011;52(Suppl 6):S437\u201351.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"4065_CR26","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.3109\/10428194.2015.1023724","volume":"56","author":"JA Trubiano","year":"2015","unstructured":"Trubiano JA, Leung VK, Worth LJ, Teh BW, Thursky KA, Slavin MA. Candida glabrata fungaemia at an Australian cancer Centre: epidemiology, risk factors and therapy. Leuk Lymphoma. 2015;56(12):3442\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"4065_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(18)30491-2","volume":"18","author":"ML Grayson","year":"2018","unstructured":"Grayson ML, Stewardson AJ, Russo PL, Ryan KE, Olsen KL, Havers SM, et al. Effects of the Australian National Hand Hygiene Initiative after 8 years on infection control practices, health-care worker education, and clinical outcomes: a longitudinal study. Lancet Infect Dis. 2018;18(11):1269\u201377.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"4065_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajic.2008.06.003","volume":"36","author":"VD Rosenthal","year":"2008","unstructured":"Rosenthal VD, Maki DG, Graves N. The international nosocomial infection control consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008;36(9):e1\u201312.","journal-title":"Am J Infect Control"},{"issue":"12","key":"4065_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/myc.12531","volume":"59","author":"R Khatib","year":"2016","unstructured":"Khatib R, Johnson LB, Fakih MG, Riederer K, Briski L. Current trends in candidemia and species distribution among adults: Candida glabrata surpasses C. albicans in diabetic patients and abdominal sources. Mycoses. 2016;59(12):781\u20136.","journal-title":"Mycoses."},{"issue":"3","key":"4065_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/CCM.0b013e3181cc4734","volume":"38","author":"Y Cohen","year":"2010","unstructured":"Cohen Y, Karoubi P, Adrie C, Gauzit R, Marsepoil T, Zarka D, et al. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Crit Care Med. 2010;38(3):826\u201330.","journal-title":"Crit Care Med"},{"issue":"3","key":"4065_CR31","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molimm.2011.09.023","volume":"49","author":"K Kristof","year":"2011","unstructured":"Kristof K, Madach K, Sandor N, Ivanyi Z, Kiraly A, Erdei A, et al. Impact of molecular mimicry on the clinical course and outcome of sepsis syndrome. Mol Immunol. 2011;49(3):512\u20137.","journal-title":"Mol Immunol"},{"issue":"1","key":"4065_CR32","doi-asserted-by":"publisher","first-page":"87 e1","DOI":"10.1016\/j.cmi.2014.08.011","volume":"21","author":"L Klingspor","year":"2015","unstructured":"Klingspor L, Tortorano AM, Peman J, Willinger B, Hamal P, Sendid B, et al. Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). Clin Microbiol Infect. 2015;21(1):87 e1\u2013e10.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4065_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cid\/cir355","volume":"53","author":"AM Oude Lashof","year":"2011","unstructured":"Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53(3):262\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4065_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for Sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762\u201374.","journal-title":"JAMA."},{"issue":"5","key":"4065_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.chest.2016.02.653","volume":"149","author":"SQ Simpson","year":"2016","unstructured":"Simpson SQ. New Sepsis criteria: a change we should not make. Chest. 2016;149(5):1117\u20138.","journal-title":"Chest."},{"key":"4065_CR36","unstructured":"National health and medical research council (NHMRC). Australian guidelines for the prevention and control of infection in healthcare. Commonwealth of Australia. 2010."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4065-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4065-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4065-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T23:07:28Z","timestamp":1589929648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4065-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4065"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4065-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,21]]},"assertion":[{"value":"23 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human research ethics approval was obtained for all sites, with the need for consent waived as a Low and Negligible Risk (LNR) research project, through the Western Sydney Local Health District Human Research Ethics Committee (HREC) (HREC Ref: AU RED LNR14\/WMEAD\/112).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SC, MS, SVH and DM are on the Antifungal Advisory Boards of Gilead Sciences Inc., MSD Australia and Pfizer Australia. SK is on the Antifungal Advisory Board of Pfizer Australia, MSD Australia and Mayne Pharma. TS, DM, MS, SC, SVH, NB, CK and SK have received untied grants from Gilead Sciences Inc., MSD Australia and Pfizer Australia. All other authors: none to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"445"}}